83 FR 54613 - Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 210 (October 30, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 210 (October 30, 2018)
| Page Range | 54613-54613 | |
| FR Document | 2018-23695 |
[Federal Register Volume 83, Number 210 (Tuesday, October 30, 2018)] [Notices] [Page 54613] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-23695] [[Page 54613]] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 31, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been delegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on June 14, 2018, Sigma Aldrich Research, 1-3 Strathmore Road, Natick, Massachusetts 01760-2447 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ Cathinone.......................... 1235 I Mephedrone (4-Methyl-N- 1248 I methylcathinone). Lysergic acid diethylamide......... 7315 I 3,4-Methylenedioxymethamphetamine.. 7405 I Dimethyltryptamine................. 7435 I 5-Methoxy-N,N-diisopropyltryptamine 7439 I MDPV (3,4- 7535 I Methylenedioxypyrovalerone). Heroin............................. 9200 I Normorphine........................ 9313 I Norlevorphanol..................... 9634 I Amphetamine........................ 1100 II Nabilone........................... 7379 II Cocaine............................ 9041 II Codeine............................ 9050 II Ecgonine........................... 9180 II Levorphanol........................ 9220 II Meperidine......................... 9230 II Methadone.......................... 9250 II Morphine........................... 9300 II Thebaine........................... 9333 II Levo-alphacetylmethadol............ 9648 II Remifentanil....................... 9739 II Sufentanil......................... 9740 II Carfentanil........................ 9743 II Fentanyl........................... 9801 II ------------------------------------------------------------------------ The company plans to manufacture reference standards. Dated: October 11, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018-23695 Filed 10-29-18; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 83, No. 210 / Tuesday, October 30, 2018 / Notices 54613
DEPARTMENT OF JUSTICE ADDRESSES: Written comments should manufacturers, distributors, dispensers,
be sent to: Drug Enforcement importers, and exporters of controlled
Drug Enforcement Administration Administration, Attention: DEA Federal substances (other than final orders in
Register Representative/DPW, 8701 connection with suspension, denial, or
[Docket No. DEA–392]
Morrissette Drive, Springfield, Virginia revocation of registration) has been
Bulk Manufacturer of Controlled 22152. delegated to the Assistant Administrator
Substances Application: Sigma Aldrich of the DEA Diversion Control Division
Research SUPPLEMENTARY INFORMATION: The (‘‘Assistant Administrator’’) pursuant to
Attorney General has delegated his section 7 of 28 CFR part 0, appendix to
ACTION: Notice of application. authority under the Controlled subpart R.
Substances Act to the Administrator of In accordance with 21 CFR
DATES: Registered bulk manufacturers of the Drug Enforcement Administration 1301.33(a), this is notice that on June
the affected basic classes, and (DEA), 28 CFR 0.100(b). Authority to 14, 2018, Sigma Aldrich Research, 1–3
applicants therefore, may file written exercise all necessary functions with Strathmore Road, Natick, Massachusetts
comments on or objections to the respect to the promulgation and 01760–2447 applied to be registered as
issuance of the proposed registration on implementation of 21 CFR part 1301, a bulk manufacturer of the following
or before December 31, 2018. incident to the registration of basic classes of controlled substances:
Controlled substance Drug code Schedule
Cathinone ........................................................................................................................................................................ 1235 I
Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 1248 I
Lysergic acid diethylamide .............................................................................................................................................. 7315 I
3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I
Dimethyltryptamine .......................................................................................................................................................... 7435 I
5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. 7439 I
MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 7535 I
Heroin .............................................................................................................................................................................. 9200 I
Normorphine .................................................................................................................................................................... 9313 I
Norlevorphanol ................................................................................................................................................................ 9634 I
Amphetamine ................................................................................................................................................................... 1100 II
Nabilone ........................................................................................................................................................................... 7379 II
Cocaine ............................................................................................................................................................................ 9041 II
Codeine ........................................................................................................................................................................... 9050 II
Ecgonine .......................................................................................................................................................................... 9180 II
Levorphanol ..................................................................................................................................................................... 9220 II
Meperidine ....................................................................................................................................................................... 9230 II
Methadone ....................................................................................................................................................................... 9250 II
Morphine .......................................................................................................................................................................... 9300 II
Thebaine .......................................................................................................................................................................... 9333 II
Levo-alphacetylmethadol ................................................................................................................................................. 9648 II
Remifentanil ..................................................................................................................................................................... 9739 II
Sufentanil ......................................................................................................................................................................... 9740 II
Carfentanil ....................................................................................................................................................................... 9743 II
Fentanyl ........................................................................................................................................................................... 9801 II
The company plans to manufacture issuance of the proposed registration on SUPPLEMENTARY INFORMATION:
reference standards. or before November 29, 2018. Such The Attorney General has delegated
Dated: October 11, 2018. persons may also file a written request his authority under the Controlled
for a hearing on the application on or Substances Act to the Administrator of
John J. Martin,
before November 29, 2018. the Drug Enforcement Administration
Assistant Administrator. (DEA), 28 CFR 0.100(b). Authority to
[FR Doc. 2018–23695 Filed 10–29–18; 8:45 am] ADDRESSES: Written comments should exercise all necessary functions with
BILLING CODE 4410–09–P be sent to: Drug Enforcement respect to the promulgation and
Administration, Attention: DEA Federal implementation of 21 CFR part 1301,
Register Representative/DPW, 8701 incident to the registration of
DEPARTMENT OF JUSTICE Morrissette Drive, Springfield, Virginia manufacturers, distributors, dispensers,
22152. All requests for hearing must be importers, and exporters of controlled
Drug Enforcement Administration sent to: Drug Enforcement substances (other than final orders in
Administration, Attn: Administrator, connection with suspension, denial, or
[Docket No. DEA–392]
8701 Morrissette Drive, Springfield, revocation of registration) has been
Importer of Controlled Substances Virginia 22152. All requests for hearing redelegated to the Assistant
should also be sent to: (1) Drug
khammond on DSK30JT082PROD with NOTICES
Application: Catalent CTS, LLC Administrator of the DEA Diversion
Enforcement Administration, Attn: Control Division (‘‘Assistant
ACTION: Notice of application. Hearing Clerk/OALJ, 8701 Morrissette Administrator’’) pursuant to section 7 of
Drive, Springfield, Virginia 22152; and 28 CFR part 0, appendix to subpart R.
DATES: Registered bulk manufacturers of (2) Drug Enforcement Administration, In accordance with 21 CFR
the affected basic classes, and Attn: DEA Federal Register 1301.34(a), this is notice that on July 17,
applicants therefore, may file written Representative/DPW, 8701 Morrissette 2018, Catalent CTS, LLC, 10245
comments on or objections to the Drive, Springfield, Virginia 22152. Hickman Mills Drive, Kansas City,
VerDate Sep<11>2014 17:34 Oct 29, 2018 Jkt 247001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\30OCN1.SGM 30OCN1](https://thefederalregister.org/doc/83_FR_54823/page/1.svg)
Document Created: 2018-10-30 00:43:18
Document Modified: 2018-10-30 00:43:18
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 31, 2018. | |
| FR Citation | 83 FR 54613 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR